10 20 30 40 50 60 70 80 2RJS - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ISOMERASE 15-OCT-07 2RJS
TITLE SGTAM BOUND TO SUBSTRATE MIMIC
CAVEAT 2RJS INCORRECT CHIRALITY AT ASP 535 CA
COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE AMINOMUTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TYROSINE AMINOMUTASE; COMPND 5 SYNONYM: PUTATIVE AMMONIA LYASE/TRANSFERASE; COMPND 6 EC: 5.4.3.6; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES GLOBISPORUS; SOURCE 3 ORGANISM_TAXID: 1908; SOURCE 4 GENE: SGCC4; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A
KEYWDS 4-METHYLIDENE IMIDAZOLE, MIO, AMINOMUTASE, C-1027, ISOMERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR T.J.MONTAVON,C.V.CHRISTIANSON,S.D.BRUNER
REVDAT 3 24-FEB-09 2RJS 1 VERSN REVDAT 2 22-JUL-08 2RJS 1 JRNL LINK REMARK REVDAT 1 15-JAN-08 2RJS 0
JRNL AUTH T.J.MONTAVON,C.V.CHRISTIANSON,G.M.FESTIN,B.SHEN, JRNL AUTH 2 S.D.BRUNER JRNL TITL DESIGN AND CHARACTERIZATION OF MECHANISM-BASED JRNL TITL 2 INHIBITORS FOR THE TYROSINE AMINOMUTASE SGTAM. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 3099 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18078753 JRNL DOI 10.1016/J.BMCL.2007.11.046
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 37827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.400 REMARK 3 FREE R VALUE TEST SET COUNT : 3812 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.6000 REMARK 3 BIN FREE R VALUE : 0.4790 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8021 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 398 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.84500 REMARK 3 B22 (A**2) : 6.69500 REMARK 3 B33 (A**2) : 0.15100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.175 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.802 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.893 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.767 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 46.56 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_MDO_7.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NEWMETYR.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2RJS COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-07. REMARK 100 THE RCSB ID CODE IS RCSB044944.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(III)CRYSTAL REMARK 200 OPTICS : CHANNEL-CUT SI(111) CRYSTAL REMARK 200 MONOCHROMATOR FOLLOWED BY A REMARK 200 DOUBLY FOCUSING TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : HKL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2OHY REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4.4 M SODIUM FORMATE, 100 MM TMAO, REMARK 280 PH 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 46.24700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 73.14300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.24700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 73.14300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 33690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -165.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 3 REMARK 465 THR A 4 REMARK 465 GLN A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 7 REMARK 465 THR A 8 REMARK 465 GLU A 9 REMARK 465 ILE A 10 REMARK 465 VAL A 11 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 LEU B 3 REMARK 465 THR B 4 REMARK 465 GLN B 5 REMARK 465 VAL B 6 REMARK 465 GLU B 7 REMARK 465 THR B 8 REMARK 465 GLU B 9 REMARK 465 ILE B 10
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB2 MDO B 152 F2 296 B 1001 2.05 REMARK 500 OH TYR B 308 F2 296 A 1001 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 18 -40.96 -132.50 REMARK 500 HIS A 251 -67.96 -121.98 REMARK 500 PRO A 256 50.65 -66.36 REMARK 500 ARG A 311 -42.28 -136.66 REMARK 500 ALA A 354 45.77 -153.66 REMARK 500 TYR A 393 34.86 71.91 REMARK 500 ASP A 440 13.89 -150.99 REMARK 500 LEU A 527 -18.70 72.69 REMARK 500 THR A 534 -153.59 -137.65 REMARK 500 GLU B 18 -34.54 -138.90 REMARK 500 ASN B 59 28.35 49.05 REMARK 500 GLU B 180 124.19 -39.04 REMARK 500 ARG B 196 -159.07 -103.32 REMARK 500 LYS B 198 -2.55 65.91 REMARK 500 HIS B 251 -60.41 -125.04 REMARK 500 PRO B 256 66.22 -64.51 REMARK 500 ALA B 293 -18.14 -43.72 REMARK 500 ALA B 354 51.09 -149.47 REMARK 500 GLN B 433 30.56 -94.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 534 ASP A 535 139.49 REMARK 500 ILE B 147 GLY B 148 147.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (11X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASP A 535 133.1 ALPHA-CARBON REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 296 B 1001 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 296 A 1001
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OHY RELATED DB: PDB REMARK 900 NATIVE SGTAM STUCTURE REMARK 900 RELATED ID: 2QVE RELATED DB: PDB REMARK 900 SGTAM BOUND WITH PRODUCT MIMIC REMARK 900 RELATED ID: 2RJR RELATED DB: PDB
DBREF 2RJS A 1 539 UNP Q8GMG0 Q8GMG0_STRGL 1 539 DBREF 2RJS B 1 539 UNP Q8GMG0 Q8GMG0_STRGL 1 539
SEQRES 1 A 537 MET ALA LEU THR GLN VAL GLU THR GLU ILE VAL PRO VAL SEQRES 2 A 537 SER VAL ASP GLY GLU THR LEU THR VAL GLU ALA VAL ARG SEQRES 3 A 537 ARG VAL ALA GLU GLU ARG ALA THR VAL ASP VAL PRO ALA SEQRES 4 A 537 GLU SER ILE ALA LYS ALA GLN LYS SER ARG GLU ILE PHE SEQRES 5 A 537 GLU GLY ILE ALA GLU GLN ASN ILE PRO ILE TYR GLY VAL SEQRES 6 A 537 THR THR GLY TYR GLY GLU MET ILE TYR MET GLN VAL ASP SEQRES 7 A 537 LYS SER LYS GLU VAL GLU LEU GLN THR ASN LEU VAL ARG SEQRES 8 A 537 SER HIS SER ALA GLY VAL GLY PRO LEU PHE ALA GLU ASP SEQRES 9 A 537 GLU ALA ARG ALA ILE VAL ALA ALA ARG LEU ASN THR LEU SEQRES 10 A 537 ALA LYS GLY HIS SER ALA VAL ARG PRO ILE ILE LEU GLU SEQRES 11 A 537 ARG LEU ALA GLN TYR LEU ASN GLU GLY ILE THR PRO ALA SEQRES 12 A 537 ILE PRO GLU ILE GLY SER LEU GLY MDO ASP LEU ALA PRO SEQRES 13 A 537 LEU SER HIS VAL ALA SER THR LEU ILE GLY GLU GLY TYR SEQRES 14 A 537 VAL LEU ARG ASP GLY ARG PRO VAL GLU THR ALA GLN VAL SEQRES 15 A 537 LEU ALA GLU ARG GLY ILE GLU PRO LEU GLU LEU ARG PHE SEQRES 16 A 537 LYS GLU GLY LEU ALA LEU ILE ASN GLY THR SER GLY MET SEQRES 17 A 537 THR GLY LEU GLY SER LEU VAL VAL GLY ARG ALA LEU GLU SEQRES 18 A 537 GLN ALA GLN GLN ALA GLU ILE VAL THR ALA LEU LEU ILE SEQRES 19 A 537 GLU ALA VAL ARG GLY SER THR SER PRO PHE LEU ALA GLU SEQRES 20 A 537 GLY HIS ASP ILE ALA ARG PRO HIS GLU GLY GLN ILE ASP SEQRES 21 A 537 THR ALA ALA ASN MET ARG ALA LEU MET ARG GLY SER GLY SEQRES 22 A 537 LEU THR VAL GLU HIS ALA ASP LEU ARG ARG GLU LEU GLN SEQRES 23 A 537 LYS ASP LYS GLU ALA GLY LYS ASP VAL GLN ARG SER GLU SEQRES 24 A 537 ILE TYR LEU GLN LYS ALA TYR SER LEU ARG ALA ILE PRO SEQRES 25 A 537 GLN VAL VAL GLY ALA VAL ARG ASP THR LEU TYR HIS ALA SEQRES 26 A 537 ARG HIS LYS LEU ARG ILE GLU LEU ASN SER ALA ASN ASP SEQRES 27 A 537 ASN PRO LEU PHE PHE GLU GLY LYS GLU ILE PHE HIS GLY SEQRES 28 A 537 ALA ASN PHE HIS GLY GLN PRO ILE ALA PHE ALA MET ASP SEQRES 29 A 537 PHE VAL THR ILE ALA LEU THR GLN LEU GLY VAL LEU ALA SEQRES 30 A 537 GLU ARG GLN ILE ASN ARG VAL LEU ASN ARG HIS LEU SER SEQRES 31 A 537 TYR GLY LEU PRO GLU PHE LEU VAL SER GLY ASP PRO GLY SEQRES 32 A 537 LEU HIS SER GLY PHE ALA GLY ALA GLN TYR PRO ALA THR SEQRES 33 A 537 ALA LEU VAL ALA GLU ASN ARG THR ILE GLY PRO ALA SER SEQRES 34 A 537 THR GLN SER VAL PRO SER ASN GLY ASP ASN GLN ASP VAL SEQRES 35 A 537 VAL SER MET GLY LEU ILE SER ALA ARG ASN ALA ARG ARG SEQRES 36 A 537 VAL LEU SER ASN ASN ASN LYS ILE LEU ALA VAL GLU TYR SEQRES 37 A 537 LEU ALA ALA ALA GLN ALA VAL ASP ILE SER GLY ARG PHE SEQRES 38 A 537 ASP GLY LEU SER PRO ALA ALA LYS ALA THR TYR GLU ALA SEQRES 39 A 537 VAL ARG ARG LEU VAL PRO THR LEU GLY VAL ASP ARG TYR SEQRES 40 A 537 MET ALA ASP ASP ILE GLU LEU VAL ALA ASP ALA LEU SER SEQRES 41 A 537 ARG GLY GLU PHE LEU ARG ALA ILE ALA ARG GLU THR ASP SEQRES 42 A 537 ILE GLN LEU ARG SEQRES 1 B 537 MET ALA LEU THR GLN VAL GLU THR GLU ILE VAL PRO VAL SEQRES 2 B 537 SER VAL ASP GLY GLU THR LEU THR VAL GLU ALA VAL ARG SEQRES 3 B 537 ARG VAL ALA GLU GLU ARG ALA THR VAL ASP VAL PRO ALA SEQRES 4 B 537 GLU SER ILE ALA LYS ALA GLN LYS SER ARG GLU ILE PHE SEQRES 5 B 537 GLU GLY ILE ALA GLU GLN ASN ILE PRO ILE TYR GLY VAL SEQRES 6 B 537 THR THR GLY TYR GLY GLU MET ILE TYR MET GLN VAL ASP SEQRES 7 B 537 LYS SER LYS GLU VAL GLU LEU GLN THR ASN LEU VAL ARG SEQRES 8 B 537 SER HIS SER ALA GLY VAL GLY PRO LEU PHE ALA GLU ASP SEQRES 9 B 537 GLU ALA ARG ALA ILE VAL ALA ALA ARG LEU ASN THR LEU SEQRES 10 B 537 ALA LYS GLY HIS SER ALA VAL ARG PRO ILE ILE LEU GLU SEQRES 11 B 537 ARG LEU ALA GLN TYR LEU ASN GLU GLY ILE THR PRO ALA SEQRES 12 B 537 ILE PRO GLU ILE GLY SER LEU GLY MDO ASP LEU ALA PRO SEQRES 13 B 537 LEU SER HIS VAL ALA SER THR LEU ILE GLY GLU GLY TYR SEQRES 14 B 537 VAL LEU ARG ASP GLY ARG PRO VAL GLU THR ALA GLN VAL SEQRES 15 B 537 LEU ALA GLU ARG GLY ILE GLU PRO LEU GLU LEU ARG PHE SEQRES 16 B 537 LYS GLU GLY LEU ALA LEU ILE ASN GLY THR SER GLY MET SEQRES 17 B 537 THR GLY LEU GLY SER LEU VAL VAL GLY ARG ALA LEU GLU SEQRES 18 B 537 GLN ALA GLN GLN ALA GLU ILE VAL THR ALA LEU LEU ILE SEQRES 19 B 537 GLU ALA VAL ARG GLY SER THR SER PRO PHE LEU ALA GLU SEQRES 20 B 537 GLY HIS ASP ILE ALA ARG PRO HIS GLU GLY GLN ILE ASP SEQRES 21 B 537 THR ALA ALA ASN MET ARG ALA LEU MET ARG GLY SER GLY SEQRES 22 B 537 LEU THR VAL GLU HIS ALA ASP LEU ARG ARG GLU LEU GLN SEQRES 23 B 537 LYS ASP LYS GLU ALA GLY LYS ASP VAL GLN ARG SER GLU SEQRES 24 B 537 ILE TYR LEU GLN LYS ALA TYR SER LEU ARG ALA ILE PRO SEQRES 25 B 537 GLN VAL VAL GLY ALA VAL ARG ASP THR LEU TYR HIS ALA SEQRES 26 B 537 ARG HIS LYS LEU ARG ILE GLU LEU ASN SER ALA ASN ASP SEQRES 27 B 537 ASN PRO LEU PHE PHE GLU GLY LYS GLU ILE PHE HIS GLY SEQRES 28 B 537 ALA ASN PHE HIS GLY GLN PRO ILE ALA PHE ALA MET ASP SEQRES 29 B 537 PHE VAL THR ILE ALA LEU THR GLN LEU GLY VAL LEU ALA SEQRES 30 B 537 GLU ARG GLN ILE ASN ARG VAL LEU ASN ARG HIS LEU SER SEQRES 31 B 537 TYR GLY LEU PRO GLU PHE LEU VAL SER GLY ASP PRO GLY SEQRES 32 B 537 LEU HIS SER GLY PHE ALA GLY ALA GLN TYR PRO ALA THR SEQRES 33 B 537 ALA LEU VAL ALA GLU ASN ARG THR ILE GLY PRO ALA SER SEQRES 34 B 537 THR GLN SER VAL PRO SER ASN GLY ASP ASN GLN ASP VAL SEQRES 35 B 537 VAL SER MET GLY LEU ILE SER ALA ARG ASN ALA ARG ARG SEQRES 36 B 537 VAL LEU SER ASN ASN ASN LYS ILE LEU ALA VAL GLU TYR SEQRES 37 B 537 LEU ALA ALA ALA GLN ALA VAL ASP ILE SER GLY ARG PHE SEQRES 38 B 537 ASP GLY LEU SER PRO ALA ALA LYS ALA THR TYR GLU ALA SEQRES 39 B 537 VAL ARG ARG LEU VAL PRO THR LEU GLY VAL ASP ARG TYR SEQRES 40 B 537 MET ALA ASP ASP ILE GLU LEU VAL ALA ASP ALA LEU SER SEQRES 41 B 537 ARG GLY GLU PHE LEU ARG ALA ILE ALA ARG GLU THR ASP SEQRES 42 B 537 ILE GLN LEU ARG
MODRES 2RJS MDO A 152 ALA MODRES 2RJS MDO A 152 SER MODRES 2RJS MDO A 152 GLY MODRES 2RJS MDO B 152 ALA MODRES 2RJS MDO B 152 SER MODRES 2RJS MDO B 152 GLY
HET MDO A 152 13 HET MDO B 152 13 HET 296 B1001 16 HET 296 A1001 16
HETNAM MDO {2-[(1S)-1-AMINOETHYL]-5-HYDROXY-4-METHYL-1H-IMIDAZOL- HETNAM 2 MDO 1-YL}ACETIC ACID HETNAM 296 (3R)-3-AMINO-2,2-DIFLUORO-3-(4-METHOXYPHENYL) HETNAM 2 296 PROPANOIC ACID
HETSYN MDO 4-METHYLIDENE-5-ONE; PEPTIDE DERIVED CHROMOPHORE
FORMUL 1 MDO 2(C8 H13 N3 O3) FORMUL 3 296 2(C10 H11 F2 N O3) FORMUL 5 HOH *398(H2 O)
HELIX 1 1 THR A 21 GLU A 31 1 11 HELIX 2 2 PRO A 38 GLU A 57 1 20 HELIX 3 3 TYR A 69 ILE A 73 5 5 HELIX 4 4 LYS A 81 SER A 94 1 14 HELIX 5 5 ALA A 102 ALA A 118 1 17 HELIX 6 6 ARG A 125 GLY A 139 1 15 HELIX 7 7 ASP A 155 ILE A 167 1 13 HELIX 8 8 THR A 181 GLU A 187 1 7 HELIX 9 9 LYS A 198 ASN A 205 1 8 HELIX 10 10 THR A 207 VAL A 239 1 33 HELIX 11 11 THR A 243 HIS A 251 5 9 HELIX 12 12 HIS A 257 MET A 271 1 15 HELIX 13 13 GLU A 279 ASP A 290 1 12 HELIX 14 14 ALA A 307 ARG A 311 5 5 HELIX 15 15 ALA A 312 ASN A 336 1 25 HELIX 16 16 GLY A 358 ASN A 388 1 31 HELIX 17 17 PRO A 396 VAL A 400 5 5 HELIX 18 18 ALA A 413 THR A 426 1 14 HELIX 19 19 MET A 447 GLY A 481 1 35 HELIX 20 20 ARG A 482 LEU A 486 5 5 HELIX 21 21 SER A 487 ARG A 499 1 13 HELIX 22 22 MET A 510 ARG A 523 1 14 HELIX 23 23 ARG A 528 THR A 534 1 7 HELIX 24 24 THR B 21 GLU B 31 1 11 HELIX 25 25 PRO B 38 GLU B 57 1 20 HELIX 26 26 TYR B 69 ILE B 73 5 5 HELIX 27 27 LYS B 81 HIS B 93 1 13 HELIX 28 28 ALA B 102 ALA B 118 1 17 HELIX 29 29 ARG B 125 GLY B 139 1 15 HELIX 30 30 ASP B 155 ILE B 167 1 13 HELIX 31 31 THR B 181 GLU B 187 1 7 HELIX 32 32 LYS B 198 ASN B 205 1 8 HELIX 33 33 THR B 207 VAL B 239 1 33 HELIX 34 34 THR B 243 HIS B 251 5 9 HELIX 35 35 HIS B 257 MET B 271 1 15 HELIX 36 36 GLU B 279 LYS B 289 1 11 HELIX 37 37 ALA B 307 ARG B 311 5 5 HELIX 38 38 ALA B 312 ASN B 336 1 25 HELIX 39 39 GLY B 358 ASN B 388 1 31 HELIX 40 40 PRO B 396 VAL B 400 5 5 HELIX 41 41 ALA B 413 ARG B 425 1 13 HELIX 42 42 MET B 447 SER B 480 1 34 HELIX 43 43 ARG B 482 LEU B 486 5 5 HELIX 44 44 SER B 487 VAL B 501 1 15 HELIX 45 45 MET B 510 ARG B 523 1 14 HELIX 46 46 GLY B 524 THR B 534 1 11
SHEET 1 A 2 VAL A 13 SER A 14 0 SHEET 2 A 2 VAL A 35 ASP A 36 1 O ASP A 36 N VAL A 13 SHEET 1 B 2 MET A 75 VAL A 77 0 SHEET 2 B 2 VAL B 297 ARG B 299 -1 O GLN B 298 N GLN A 76 SHEET 1 C 2 VAL A 97 LEU A 100 0 SHEET 2 C 2 PRO A 145 ILE A 147 -1 O GLU A 146 N PRO A 99 SHEET 1 D 2 TYR A 171 ARG A 174 0 SHEET 2 D 2 ARG A 177 GLU A 180 -1 O VAL A 179 N VAL A 172 SHEET 1 E 2 VAL A 297 ARG A 299 0 SHEET 2 E 2 MET B 75 VAL B 77 -1 O GLN B 76 N GLN A 298 SHEET 1 F 2 VAL B 13 SER B 14 0 SHEET 2 F 2 VAL B 35 ASP B 36 1 O ASP B 36 N VAL B 13 SHEET 1 G 2 TYR B 171 ARG B 174 0 SHEET 2 G 2 ARG B 177 GLU B 180 -1 O VAL B 179 N VAL B 172
LINK CB2 MDO A 152 N10 296 A1001 1555 1555 1.59 LINK CB2 MDO B 152 N10 296 B1001 1555 1555 1.72 LINK C GLY A 151 N MDO A 152 1555 1555 1.34 LINK C MDO A 152 N ASP A 155 1555 1555 1.35 LINK C GLY B 151 N MDO B 152 1555 1555 1.34 LINK C MDO B 152 N ASP B 155 1555 1555 1.34
CISPEP 1 ASN A 341 PRO A 342 0 -0.20 CISPEP 2 VAL B 11 PRO B 12 0 -0.45 CISPEP 3 ASN B 341 PRO B 342 0 -0.29
SITE 1 AC1 11 TYR A 308 ARG A 311 TYR B 63 GLY B 70 SITE 2 AC1 11 HIS B 93 MDO B 152 LEU B 156 ASN B 205 SITE 3 AC1 11 PHE B 356 ALA B 411 TYR B 415 SITE 1 AC2 12 TYR A 63 GLY A 70 HIS A 93 MDO A 152 SITE 2 AC2 12 LEU A 156 ASN A 205 ASN A 341 PHE A 356 SITE 3 AC2 12 TYR A 415 GLN A 442 TYR B 308 ARG B 311
CRYST1 92.494 146.286 75.009 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010812 0.000000 0.000000 0.00000
SCALE2 0.000000 0.006836 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013332 0.00000